应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CNTX Context Therapeutics Inc.
休市中 08-30 16:00:00 EDT
2.46
+0.01
+0.41%
盘后
2.46
+0.00
0.00%
16:00 EDT
最高
2.49
最低
2.43
成交量
2.70万
今开
2.47
昨收
2.45
日振幅
2.45%
总市值
1.84亿
流通市值
9,612万
总股本
7,500万
成交额
6.61万
换手率
0.07%
流通股本
3,907万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Context Therapeutics Inc.2024财年第二财季实现净利润-2.25百万美元,同比增加55.09%
自选股智能写手 · 08-17
Context Therapeutics Inc.2024财年第二财季实现净利润-2.25百万美元,同比增加55.09%
Context Therapeutics Inc.盘中异动 临近午盘快速拉升5.02%
自选股智能写手 · 08-14
Context Therapeutics Inc.盘中异动 临近午盘快速拉升5.02%
Context Therapeutics Inc.盘中异动 早盘快速下挫5.42%报2.27美元
自选股智能写手 · 08-09
Context Therapeutics Inc.盘中异动 早盘快速下挫5.42%报2.27美元
Context Therapeutics Inc.盘中异动 股价大跌9.17%报2.08美元
自选股智能写手 · 08-05
Context Therapeutics Inc.盘中异动 股价大跌9.17%报2.08美元
Context Therapeutics Inc.盘中异动 股价大涨5.25%
自选股智能写手 · 07-19
Context Therapeutics Inc.盘中异动 股价大涨5.25%
Context Therapeutics Inc.盘中异动 临近午盘股价大跌5.08%
自选股智能写手 · 07-17
Context Therapeutics Inc.盘中异动 临近午盘股价大跌5.08%
HC Wainwright & Co.:重申Context Therapeutics(CNTX.US)评级,由买入调整至买入评级, 目标价由5.
智通财经 · 07-11
HC Wainwright & Co.:重申Context Therapeutics(CNTX.US)评级,由买入调整至买入评级, 目标价由5.
BUZZ-以 375 万美元收购实验性癌症疗法后,Context Therapeutics 公司股价上涨
Reuters · 07-10
BUZZ-以 375 万美元收购实验性癌症疗法后,Context Therapeutics 公司股价上涨
Context Therapeutics Inc.盘中异动 下午盘股价大跌5.16%
自选股智能写手 · 07-02
Context Therapeutics Inc.盘中异动 下午盘股价大跌5.16%
Context Therapeutics Inc.盘中异动 临近午盘急速跳水5.05%
自选股智能写手 · 06-25
Context Therapeutics Inc.盘中异动 临近午盘急速跳水5.05%
Context Therapeutics Inc.盘中异动 股价大跌5.30%报1.87美元
自选股智能写手 · 06-14
Context Therapeutics Inc.盘中异动 股价大跌5.30%报1.87美元
Context Therapeutics Inc.盘中异动 股价大涨5.96%
自选股智能写手 · 06-11
Context Therapeutics Inc.盘中异动 股价大涨5.96%
Context Therapeutics Inc.盘中异动 早盘股价大跌5.15%报1.72美元
自选股智能写手 · 06-05
Context Therapeutics Inc.盘中异动 早盘股价大跌5.15%报1.72美元
Context Therapeutics Inc.盘中异动 股价大跌5.39%
自选股智能写手 · 06-04
Context Therapeutics Inc.盘中异动 股价大跌5.39%
Context Therapeutics Inc.盘中异动 下午盘股价大涨5.00%
自选股智能写手 · 05-29
Context Therapeutics Inc.盘中异动 下午盘股价大涨5.00%
Context Therapeutics Inc.盘中异动 大幅下挫6.40%
自选股智能写手 · 05-23
Context Therapeutics Inc.盘中异动 大幅下挫6.40%
Context Therapeutics(CNTX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价4.
智通财经 · 05-16
Context Therapeutics(CNTX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价4.
Context Therapeutics Inc.盘中异动 股价大跌5.35%
自选股智能写手 · 05-13
Context Therapeutics Inc.盘中异动 股价大跌5.35%
Context Therapeutics Inc.盘中异动 临近午盘急速上涨5.23%
自选股智能写手 · 05-08
Context Therapeutics Inc.盘中异动 临近午盘急速上涨5.23%
Context Therapeutics Inc.盘中异动 早盘急速跳水5.01%报1.69美元
自选股智能写手 · 05-07
Context Therapeutics Inc.盘中异动 早盘急速跳水5.01%报1.69美元
加载更多
公司概况
公司名称:
Context Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Context Therapeutics Inc.于2015年4月在特拉华州成立。这是一家临床阶段的生物制药公司,致力于改善罹患癌症的妇女的生活。肿瘤学药物开发的深远进展扩大了癌症女性可获得的治疗选择,但是治疗耐药性和复发继续限制了此类治疗的功效和持续时间。
发行价格:
--
{"stockData":{"symbol":"CNTX","market":"US","secType":"STK","nameCN":"Context Therapeutics Inc.","latestPrice":2.46,"timestamp":1725048000000,"preClose":2.45,"halted":0,"volume":27021,"hourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.46,"latestTime":"16:00 EDT","volume":13,"amount":31.98,"timestamp":1725048005919},"delay":0,"floatShares":39074195,"shares":74998312,"eps":-0.722047,"marketStatus":"休市中","marketStatusCode":7,"change":0.01,"latestTime":"08-30 16:00:00 EDT","open":2.47,"high":2.49,"low":2.43,"amount":66142.53071,"amplitude":0.02449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.722047,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1725350400000},"adr":0,"listingDate":1634702400000,"adjPreClose":2.45,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.45,"latestTime":"08:11 EDT","volume":1,"amount":2.4,"timestamp":1725019905374},"postHourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.46,"latestTime":"16:00 EDT","volume":13,"amount":31.98,"timestamp":1725048005919},"volumeRatio":0.2976149830803338},"requestUrl":"/m/hq/s/CNTX","defaultTab":"news","newsList":[{"id":"2460244861","title":"Context Therapeutics Inc.2024财年第二财季实现净利润-2.25百万美元,同比增加55.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460244861","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460244861?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824037,"startTime":"0","endTime":"0","summary":"8月17日,Context Therapeutics Inc.公布财报,公告显示公司2024财年第二财季净利润为-2.25百万美元,同比增加55.09%;其中营业收入为0.00美元,每股基本收益为-0.04美元。机构评级:截至2024年8月17日,当前有3家机构对Context Therapeutics Inc.目标价做出预测,其中目标均价为6.83美元,其中最低目标价为4.50美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006109f31b156&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006109f31b156&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX"],"gpt_icon":0},{"id":"2459101531","title":"Context Therapeutics Inc.盘中异动 临近午盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459101531","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459101531?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:34","pubTimestamp":1723649685,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时34分,Context Therapeutics Inc.股票出现异动,股价大幅上涨5.02%。截至发稿,该股报2.51美元/股,成交量4.5057万股,换手率0.06%,振幅6.69%。Context Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423344698e34f3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423344698e34f3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CNTX"],"gpt_icon":0},{"id":"2458914955","title":"Context Therapeutics Inc.盘中异动 早盘快速下挫5.42%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458914955","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458914955?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:10","pubTimestamp":1723212620,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时10分,Context Therapeutics Inc.股票出现波动,股价大幅下挫5.42%。截至发稿,该股报2.27美元/股,成交量3.6146万股,换手率0.05%,振幅8.30%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.48%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大,Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃,换手率分别为48.58%、46.97%、16.85%,振幅较大的相关个股有Cingulate Inc.、An2 Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.,振幅分别为34.60%、22.48%、22.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809221020af96d45f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809221020af96d45f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2457977563","title":"Context Therapeutics Inc.盘中异动 股价大跌9.17%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457977563","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457977563?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:34","pubTimestamp":1722864842,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时34分,Context Therapeutics Inc.股票出现波动,股价急速跳水9.17%。截至发稿,该股报2.08美元/股,成交量2230股,换手率0.00%,振幅5.68%。Context Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.84%。其相关个股中,Zevra Therapeutics, Inc.、Cervomed Inc.、Okyo Pharma Ltd Com Npv 涨幅较大,Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃,换手率分别为998.74%、39.48%、13.57%,振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Vor Biopharma Inc.、Compass Therapeutics, Inc.,振幅分别为17.59%、13.04%、12.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052134029f10700d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052134029f10700d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CNTX","BK4139"],"gpt_icon":0},{"id":"2452361430","title":"Context Therapeutics Inc.盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452361430","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452361430?lang=zh_cn&edition=full","pubTime":"2024-07-19 01:43","pubTimestamp":1721324626,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日01时43分,Context Therapeutics Inc.股票出现异动,股价快速拉升5.25%。截至发稿,该股报2.15美元/股,成交量5.7311万股,换手率0.08%,振幅5.39%。Context Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.66%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃,换手率分别为2614.87%、2505.56%、1273.97%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、86.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190143469681e214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190143469681e214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CNTX","BK4139"],"gpt_icon":0},{"id":"2452161326","title":"Context Therapeutics Inc.盘中异动 临近午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452161326","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452161326?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:36","pubTimestamp":1721230565,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时36分,Context Therapeutics Inc.股票出现异动,股价快速下跌5.08%。截至发稿,该股报2.08美元/股,成交量4.22万股,换手率0.06%,振幅5.53%。Context Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为2.04%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233605af92cd11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233605af92cd11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CNTX"],"gpt_icon":0},{"id":"2450845618","title":"HC Wainwright & Co.:重申Context Therapeutics(CNTX.US)评级,由买入调整至买入评级, 目标价由5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450845618","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450845618?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:13","pubTimestamp":1720631596,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4139","CNTX","LENZ"],"gpt_icon":0},{"id":"2450809812","title":"BUZZ-以 375 万美元收购实验性癌症疗法后,Context Therapeutics 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2450809812","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450809812?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:33","pubTimestamp":1720625621,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 7月10日 - ** Context Therapeutics 股价上涨2.8%至2.00美元 ** 药物开发商称已从私人控股的 Link Immunotherapeutics 公司获得一种实验性癌症疗法** CNTX 一次性支付了 375 万美元** 公司将于 2025 年第一季度开始 CT-95 疗法的早期试验** 截至目前,股价上涨 77.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","LENZ","BK4139","BUZZ","BK4007"],"gpt_icon":0},{"id":"2448945946","title":"Context Therapeutics Inc.盘中异动 下午盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448945946","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448945946?lang=zh_cn&edition=full","pubTime":"2024-07-02 01:48","pubTimestamp":1719856130,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日01时48分,Context Therapeutics Inc.股票出现异动,股价急速下跌5.16%。截至发稿,该股报1.90美元/股,成交量3.1873万股,换手率0.04%,振幅5.49%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702014851af900b90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702014851af900b90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CNTX","BK4007"],"gpt_icon":0},{"id":"2446823795","title":"Context Therapeutics Inc.盘中异动 临近午盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446823795","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446823795?lang=zh_cn&edition=full","pubTime":"2024-06-25 23:41","pubTimestamp":1719330067,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日23时41分,Context Therapeutics Inc.股票出现异动,股价大幅下挫5.05%。截至发稿,该股报2.07美元/股,成交量10.6295万股,换手率0.14%,振幅6.38%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.81%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625234107aef68a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625234107aef68a3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CNTX"],"gpt_icon":0},{"id":"2443678817","title":"Context Therapeutics Inc.盘中异动 股价大跌5.30%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443678817","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443678817?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:35","pubTimestamp":1718372104,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时35分,Context Therapeutics Inc.股票出现波动,股价大幅跳水5.30%。截至发稿,该股报1.87美元/股,成交量302股,换手率0.00%,振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421350495b0c3c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421350495b0c3c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CNTX","BK4139"],"gpt_icon":0},{"id":"2442439464","title":"Context Therapeutics Inc.盘中异动 股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442439464","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442439464?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:39","pubTimestamp":1718113199,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日21时39分,Context Therapeutics Inc.股票出现波动,股价快速拉升5.96%。截至发稿,该股报2.05美元/股,成交量2.0275万股,换手率0.03%,振幅6.42%。Context Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611214000af8cf48a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611214000af8cf48a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2441277062","title":"Context Therapeutics Inc.盘中异动 早盘股价大跌5.15%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441277062","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441277062?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:48","pubTimestamp":1717598904,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时48分,Context Therapeutics Inc.股票出现波动,股价急速跳水5.15%。截至发稿,该股报1.72美元/股,成交量10.3363万股,换手率0.14%,振幅5.71%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.83%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224825941ec986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224825941ec986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CNTX","LENZ"],"gpt_icon":0},{"id":"2440236740","title":"Context Therapeutics Inc.盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440236740","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440236740?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:03","pubTimestamp":1717509796,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时03分,Context Therapeutics Inc.股票出现波动,股价快速下挫5.39%。截至发稿,该股报1.93美元/股,成交量7214股,换手率0.01%,振幅2.40%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604220317af8bef47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604220317af8bef47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2439583102","title":"Context Therapeutics Inc.盘中异动 下午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439583102","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439583102?lang=zh_cn&edition=full","pubTime":"2024-05-29 01:21","pubTimestamp":1716916915,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日01时21分,Context Therapeutics Inc.股票出现波动,股价快速拉升5.00%。截至发稿,该股报2.10美元/股,成交量12.3407万股,换手率0.16%,振幅9.00%。Context Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.85%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052901215596810492&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052901215596810492&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2437214900","title":"Context Therapeutics Inc.盘中异动 大幅下挫6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437214900","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437214900?lang=zh_cn&edition=full","pubTime":"2024-05-23 02:10","pubTimestamp":1716401419,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日02时10分,Context Therapeutics Inc.股票出现异动,股价急速跳水6.40%。截至发稿,该股报1.90美元/股,成交量6.1006万股,换手率0.08%,振幅3.45%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.17%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230210199680f174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230210199680f174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CNTX"],"gpt_icon":0},{"id":"2435622133","title":"Context Therapeutics(CNTX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价4.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435622133","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435622133?lang=zh_cn&edition=full","pubTime":"2024-05-16 17:34","pubTimestamp":1715852041,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2435374953","title":"Context Therapeutics Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435374953","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435374953?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:52","pubTimestamp":1715611958,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时52分,Context Therapeutics Inc.股票出现异动,股价大幅下跌5.35%。截至发稿,该股报1.77美元/股,成交量6.2198万股,换手率0.08%,振幅5.35%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.19%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513225239861ecd95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513225239861ecd95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2434877327","title":"Context Therapeutics Inc.盘中异动 临近午盘急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434877327","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434877327?lang=zh_cn&edition=full","pubTime":"2024-05-08 23:58","pubTimestamp":1715183920,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日23时58分,Context Therapeutics Inc.股票出现波动,股价大幅拉升5.23%。截至发稿,该股报1.81美元/股,成交量4.1256万股,换手率0.26%,振幅7.85%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Context Therapeutics Inc.公司简介:Context Therapeutics Inc 是一家临床阶段的生物制药公司,致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508235841861ebd43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508235841861ebd43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2433255788","title":"Context Therapeutics Inc.盘中异动 早盘急速跳水5.01%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433255788","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433255788?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:34","pubTimestamp":1715088858,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时34分,Context Therapeutics Inc.股票出现波动,股价快速下挫5.01%。截至发稿,该股报1.69美元/股,成交量9027股,换手率0.06%,振幅1.31%。Context Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.53%。其相关个股中,Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nanoviricides, Inc.涨幅较大,Clearmind Medicine Inc.、Tc Biopharm Plc、Allarity Therapeutics, Inc.较为活跃,换手率分别为933.02%、94.99%、32.52%,振幅较大的相关个股有Clearmind Medicine Inc.、Nanoviricides, Inc.、Heron Therapeutics, Inc.,振幅分别为21.37%、12.14%、11.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072134197a588573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072134197a588573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CNTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.contexttherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0081},{"period":"1month","weight":0.1389},{"period":"3month","weight":0.2424},{"period":"6month","weight":1.1391},{"period":"1year","weight":1.3883},{"period":"ytd","weight":1.177}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0689},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2516},{"period":"ytd","weight":0.1859}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Context Therapeutics Inc.于2015年4月在特拉华州成立。这是一家临床阶段的生物制药公司,致力于改善罹患癌症的妇女的生活。肿瘤学药物开发的深远进展扩大了癌症女性可获得的治疗选择,但是治疗耐药性和复发继续限制了此类治疗的功效和持续时间。","exchange":"NASDAQ","name":"Context Therapeutics Inc.","nameEN":"Context Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Context Therapeutics Inc.,CNTX,Context Therapeutics Inc.股票,Context Therapeutics Inc.股票老虎,Context Therapeutics Inc.股票老虎国际,Context Therapeutics Inc.行情,Context Therapeutics Inc.股票行情,Context Therapeutics Inc.股价,Context Therapeutics Inc.股市,Context Therapeutics Inc.股票价格,Context Therapeutics Inc.股票交易,Context Therapeutics Inc.股票购买,Context Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}